Patents by Inventor Abhishek KULKARNI

Abhishek KULKARNI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240180598
    Abstract: A fixation device for providing rotation stability to a femoral neck fracture. The device includes a bone plate having at least one opening, a compression screw housing extendable through the opening of the bone plate, a compression screw being at least partially disposed within the bore of the housing and selectively moveable through the bore, and a collapsible and expandable anchoring member coupled to the compression screw. The anchoring member is configured to transition between a collapsed condition and an expanded condition upon advancement of the anchoring member from the compression screw housing to rotationally stabilize the compression screw within a femur.
    Type: Application
    Filed: February 13, 2024
    Publication date: June 6, 2024
    Inventors: Jetinder Singh, Venkateswaran Perumal, Harpreet Singh, Diksha Babhoota, Abhishek Kulkarni
  • Patent number: 11918261
    Abstract: A fixation device for providing rotation stability to a femoral neck fracture. The device includes a bone plate having at least one opening, a compression screw housing extendable through the opening of the bone plate, a compression screw being at least partially disposed within the bore of the housing and selectively moveable through the bore, and a collapsible and expandable anchoring member coupled to the compression screw. The anchoring member is configured to transition between a collapsed condition and an expanded condition upon advancement of the anchoring member from the compression screw housing to rotationally stabilize the compression screw within a femur.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: March 5, 2024
    Assignee: Stryker European Operations Limited
    Inventors: Jetinder Singh, Venkateswaran Perumal, Harpreet Singh, Diksha Babhoota, Abhishek Kulkarni
  • Publication number: 20240053176
    Abstract: Methods, systems, and storage media for providing a calibration testing template are disclosed. Exemplary implementations may: provide, at a user interface and using at least one processor associated with a calibration testing template, a customized testing data sheet comprising a plurality of test points; receive, from the test data input cell and using the at least one processor, a test data input associated with an equipment item; receive, from the test data output cell and using the at least one processor, a test data output associated with the equipment item; determine, using the at least one processor and based on the received test data input and test data output, an output error; and determine, using the at least one processor and based on the determined output error, a status result of the equipment item.
    Type: Application
    Filed: June 7, 2023
    Publication date: February 15, 2024
    Inventors: Tejas Yadav, James Wilton, Abhishek Kulkarni, Neeru Singla
  • Publication number: 20230406927
    Abstract: Certain embodiments of the invention provide a masked single-domain antibody as described herein, as well as methods of use thereof. Certain embodiments of the invention provide a masked CSAN as described herein, as well as methods of use thereof.
    Type: Application
    Filed: May 1, 2023
    Publication date: December 21, 2023
    Applicant: Regents of the University of Minnesota
    Inventors: Carston R. Wagner, Abhishek Kulkarni
  • Patent number: 11666642
    Abstract: The present invention relates to compositions and methods for the regulated and controlled expression of proteins. Methods for inducing anti-cancer immune responses in a subject are also provided.
    Type: Grant
    Filed: February 1, 2022
    Date of Patent: June 6, 2023
    Assignee: OBSIDIAN THERAPEUTICS, INC.
    Inventors: Vipin Suri, Byron Delabarre, Michael N. Gladstone, Celeste Richardson, Brian Dolinski, Abhishek Kulkarni, Mara Christine Inniss, Dexue Sun, Dan Jun Li, Grace Y. Olinger, Scott Francis Heller
  • Publication number: 20230092895
    Abstract: The present invention provides biocircuit systems, effector modules and compositions for cancer immunotherapy. Methods for inducing anti-cancer immune responses in a subject are also provided.
    Type: Application
    Filed: August 30, 2019
    Publication date: March 23, 2023
    Inventors: Vipin Suri, Michael Joseph Briskin, Brian Dolinski, Kutlu Goksu Elpek, Tucker Ezell, Scott Francis Heller, Mara Christine Inniss, Tariq A. Kassum, Nicole Kosmider, Abhishek Kulkarni, Meghan Langley, Dan Jun Li, Michelle Lynn Ols, Benjamin J. Primack, Celeste Richardson, Steven Mark Shamah, James Storer, Dexue Sun, Vijaya Balakrishnan, Andrew R.M. Bradbury, Michael Frank Erasmus, Fortunato Ferrara
  • Publication number: 20230074330
    Abstract: The present invention relates to compositions and methods for the regulated and controlled expression of proteins. Methods for inducing anti-cancer immune responses in a subject are also provided.
    Type: Application
    Filed: February 1, 2022
    Publication date: March 9, 2023
    Applicant: Obsidian Therapeutics, Inc.
    Inventors: Vipin Suri, Byron Delabarre, Michael N. Gladstone, Celeste Richardson, Brian Dolinski, Abhishek Kulkarni, Mara Christine Inniss, Dexue Sun, Dan Jun Li, Grace Y. Olinger, Scott Francis Heller
  • Publication number: 20230026259
    Abstract: The present disclosure provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities. In particular, the present application is directed to fusion proteins comprising a fragment of human human carbonic anhydrase 2 and a chimeric antigen receptor (CAR). The activity of the destabilizing domain can be regulated by externally administered agents.
    Type: Application
    Filed: March 6, 2020
    Publication date: January 26, 2023
    Applicant: Obsidian Therapeutics, Inc.
    Inventors: Vipin SURI, Celeste RICHARDSON, Brian DOLINSKI, Abhishek KULKARNI, Mara Christine Inniss, Dexue SUN, Elizabeth Jane WEISMAN, Grace Y. Olinger, Scott Francis HELLER, Jennifer Leah GORI, Michelle Lynn OLS, Kutlu Goksu ELPEK, Tucker Read EZELL, Michael SCHEBESTA, Michelle Lois FLEURY, Dhruv Kam SETHI
  • Publication number: 20220403001
    Abstract: The present disclosure relates to tunable biocircuit systems for the development of controlled and/or regulated therapeutic systems. In particular, regulatable biocircuits containing destabilizing domains (DD) derived from mutant human cGMP-specific phosphodiesterase type 5 (PDE5) are disclosed. Especially, the present disclosure provides an effector module. Such effector module may include (a) a stimulus response element (SRE), wherein the SRE is a DD, said DD comprising at least one mutation relative to cGMP-specific 3?,5?-cyclic phosphodiesterase (hPDE5; SEQ ID NO: 1) and (b) at least one payload, which is attached, appended or associated with said SRE. The SRE may be responsive to one or more stimuli.
    Type: Application
    Filed: June 12, 2019
    Publication date: December 22, 2022
    Applicant: Obsidian Therapeutics, Inc.
    Inventors: Vipin SURI, Celeste RICHARDSON, Brian DOLINSKI, Abhishek KULKARNI, Mara Christine INNISS, Dexue SUN, Dan Jun LI, Grace Y. OLINGER, Scott Francis HELLER, Jennifer Leah GORI, Byron DELABARRE
  • Publication number: 20220056092
    Abstract: The present disclosure provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities.
    Type: Application
    Filed: December 11, 2019
    Publication date: February 24, 2022
    Applicant: Obsidian Therapeutics, Inc.
    Inventors: Michelle Lynn OLS, Vipin SURI, Dexue SUN, Dan Jun LI, Dhruv Kam SETHI, Abhishek KULKARNI, Benjamin J. PRIMACK, James STORER
  • Patent number: 11241485
    Abstract: The present invention relates to compositions and methods for the regulated and controlled expression of proteins. Methods for inducing anti-cancer immune responses in a subject are also provided.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: February 8, 2022
    Assignee: OBSIDIAN THERAPEUTICS, INC.
    Inventors: Vipin Suri, Byron Delabarre, Michael N. Gladstone, Celeste Richardson, Brian Dolinski, Abhishek Kulkarni, Mara Christine Inniss, Dexue Sun, Dan Jun Li, Grace Y. Olinger, Scott Francis Heller
  • Publication number: 20210386788
    Abstract: The present disclosure is related to compositions and methods for the regulated and controlled expression of proteins.
    Type: Application
    Filed: October 23, 2019
    Publication date: December 16, 2021
    Applicant: Obsidian Therapeutics, Inc.
    Inventors: Vipin SURI, Dexue SUN, Michelle Lynn OLS, Scott Francis HELLER, Dan Jun LI, Celeste RICHARDSON, Mara Christine INNISS, Jennifer Leah GORI, Benjamin J. PRIMACK, Abhishek KULKARNI, Brian DOLINSKI, Tucker Read EZELL, Michael SCHEBESTA, James A. STORER, Kutlu Goksu ELPEK
  • Publication number: 20200323571
    Abstract: A fixation device for providing rotation stability to a femoral neck fracture. The device includes a bone plate having at least one opening, a compression screw housing extendable through the opening of the bone plate, a compression screw being at least partially disposed within the bore of the housing and selectively moveable through the bore, and a collapsible and expandable anchoring member coupled to the compression screw. The anchoring member is configured to transition between a collapsed condition and an expanded condition upon advancement of the anchoring member from the compression screw housing to rotationally stabilize the compression screw within a femur.
    Type: Application
    Filed: March 23, 2020
    Publication date: October 15, 2020
    Inventors: Jetinder Singh, Venkateswaran Perumal, Harpreet Singh, Diksha Babhoota, Abhishek Kulkarni
  • Publication number: 20200101142
    Abstract: The present invention relates to compositions and methods for the regulated and controlled expression of proteins. Methods for inducing anti-cancer immune responses in a subject are also provided.
    Type: Application
    Filed: June 12, 2018
    Publication date: April 2, 2020
    Inventors: Vipin SURI, Byron DELABARRE, Michael N. GLADSTONE, Celeste RICHARDSON, Brian DOLINSKI, Abhishek KULKARNI, Mara Christine INNISS, Dexue SUN, Dan Jun LI, Grace Y. OLINGER, Scott Francis HELLER